A novel biomanufacturing process utilizing enzyme engineering to convert triglycerides into valuable alpha olefins. This method leverages the UndB gene for efficient biotransformation, integrating lipase hydrolysis for in situ fatty acid generation, with potential for cost-effective industrial application.
This innovative biomanufacturing process focuses on converting triglycerides into high-value alpha olefins through advanced enzyme engineering. By leveraging the UndB gene, the process offers a one-step biocatalytic pathway that is both cost-effective and efficient. The integration of lipase hydrolysis for in situ generation of fatty acid precursors enhances the overall efficiency, making it suitable for industrial applications. This approach simplifies the production of terminal alkenes, offering a sustainable alternative to traditional chemical synthesis methods.
Key features:
Process details:
Currently at Technology Readiness Level 2, this process is in the early stages of feasibility studies and lab-scale validation. Future steps include pilot-scale demonstration and further optimization for commercial viability within a projected six-month timeframe.